Activation of tumor cell proliferation by thyroid hormone in a mouse model of follicular thyroid carcinoma.

Abstract

Thyroid cancers are the most common malignancy of the endocrine system in humans. To understand the molecular genetic events underlying thyroid carcinogenesis, we have generated a mouse model that spontaneously develops follicular thyroid carcinoma similar to human thyroid cancer (Thrb(PV/PV) mouse). This mutant mouse harbors a dominant-negative mutated thyroid hormone receptor β (denoted PV). The PV mutation was identified in a patient with resistance to thyroid hormone (TH). Thrb(PV/PV) mice exhibit highly elevated serum thyroid-stimulating hormone levels and increased TH. We have previously shown that thyroid-stimulating hormone is required, but not sufficient to induce metastatic follicular thyroid cancer in Thrb(PV/PV) mice. However, whether the elevated TH also contributes to the thyroid carcinogenesis of Thrb(PV/PV) mice was not elucidated. To understand the role of TH in thyroid carcinogenesis, we blocked the production of TH by treating Thrb(PV/PV) mice with propylthiouracil (Thrb(PV/PV)-PTU mice) and compared the development of thyroid cancer in Thrb(PV/PV)-PTU and untreated Thrb(PV/PV) mice. We found that thyroid tumor growth was reduced by ∼42% in Thrb(PV/PV)-PTU mice as compared with Thrb(PV/PV) mice. Analysis by bromodeoxyuridine-nuclear labeling showed decreased incorporation of bromodeoxyuridine in thyroid tumor cells of Thrb(PV/PV)-PTU mice, indicative of decreased tumor cell proliferation. However, cleaved-caspase 3 staining showed no apparent changes in apoptosis of tumor cells in Thrb(PV/PV)-PTU mice. Molecular studies identified a marked attenuation of the PI3K-AKT-β-catenin signaling pathway that led to decreased protein levels of cyclin D2, thereby decreasing tumor cell proliferation in Thrb(PV/PV)-PTU mice. Furthermore, matrix metalloproteinase-2, a downstream target of β-catenin and a key regulator during tumor invasion and metastasis, was also decreased. Thus, the present study uncovers a critical role of TH in promoting the thyroid carcinogenesis of Thrb(PV/PV) mice via membrane signaling events. Importantly, these findings suggest that anti-thyroid drugs could be considered as possible therapeutic agents of thyroid cancer.

• Authors: C Lu, X Zhu, M C Willingham, S-Y Cheng
• Journal: Oncogene (Oncogene) Vol. 31 Issue 16 Pg. 2007-16 (Apr 19 2012) ISSN: 1476-5594 [Electronic] England
• PMID: 21909131 (Publication Type: Journal Article, Research Support, N.I.H., Intramural)

Chemical References

• Antithyroid Agents
• Cyclin D2
• Thyroid Hormone Receptors beta
• Thyroid Hormones
• Propylthiouracil
• Thyrotropin

Topics

• Adenocarcinoma, Follicular
• Animals
• Antithyroid Agents (pharmacology)
• Cell Proliferation (drug effects)
• Cyclin D2 (metabolism)
• Disease Models, Animal
• Mice
• Propylthiouracil (pharmacology)
• Signal Transduction
• Thyroid Hormone Receptors beta (genetics)
• Thyroid Hormones (physiology)
• Thyroid Neoplasms (genetics, metabolism, prevention & control)
• Thyrotropin (blood)